Joseph Frank Cotten, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Potassium Channels, Tandem Pore Domain | 9 | 2017 | 57 | 2.430 |
Why?
|
| Etomidate | 12 | 2016 | 185 | 1.540 |
Why?
|
| Respiratory Insufficiency | 7 | 2022 | 1240 | 1.350 |
Why?
|
| Respiratory System Agents | 5 | 2021 | 30 | 1.200 |
Why?
|
| Anesthetics, Inhalation | 10 | 2017 | 573 | 1.200 |
Why?
|
| Thyrotropin-Releasing Hormone | 3 | 2022 | 139 | 1.000 |
Why?
|
| Isoflurane | 5 | 2018 | 383 | 0.960 |
Why?
|
| Potassium Channel Blockers | 3 | 2014 | 162 | 0.910 |
Why?
|
| Adrenal Cortex | 4 | 2013 | 134 | 0.890 |
Why?
|
| Rats, Sprague-Dawley | 20 | 2021 | 8108 | 0.760 |
Why?
|
| Polypharmacy | 1 | 2024 | 307 | 0.730 |
Why?
|
| Hypnotics and Sedatives | 7 | 2013 | 1193 | 0.690 |
Why?
|
| Analgesics, Opioid | 6 | 2022 | 3837 | 0.670 |
Why?
|
| Respiration | 4 | 2021 | 1655 | 0.560 |
Why?
|
| Alkanes | 1 | 2017 | 39 | 0.560 |
Why?
|
| Halogenation | 1 | 2017 | 46 | 0.560 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 5 | 2000 | 453 | 0.510 |
Why?
|
| Doxapram | 3 | 2015 | 4 | 0.500 |
Why?
|
| Rats | 26 | 2021 | 23713 | 0.500 |
Why?
|
| Anesthetics | 2 | 2019 | 525 | 0.490 |
Why?
|
| Pyrroles | 5 | 2013 | 1122 | 0.470 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 36 | 0.470 |
Why?
|
| Ethanol | 2 | 2019 | 1330 | 0.460 |
Why?
|
| Triazines | 1 | 2014 | 311 | 0.400 |
Why?
|
| Anesthesia, Inhalation | 1 | 2013 | 220 | 0.390 |
Why?
|
| Anesthetics, Intravenous | 4 | 2016 | 396 | 0.390 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2019 | 2678 | 0.380 |
Why?
|
| Adrenal Cortex Diseases | 1 | 2009 | 13 | 0.340 |
Why?
|
| Rats, Inbred F344 | 3 | 2017 | 820 | 0.330 |
Why?
|
| Sulfonic Acids | 2 | 2020 | 103 | 0.300 |
Why?
|
| Xenopus laevis | 9 | 2014 | 966 | 0.270 |
Why?
|
| Fluoxetine | 2 | 2024 | 733 | 0.260 |
Why?
|
| Structure-Activity Relationship | 6 | 2015 | 3052 | 0.250 |
Why?
|
| Central Nervous System Stimulants | 3 | 2012 | 1168 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2017 | 10748 | 0.250 |
Why?
|
| Receptors, GABA-A | 6 | 2014 | 624 | 0.240 |
Why?
|
| Sufentanil | 2 | 2022 | 42 | 0.240 |
Why?
|
| Benzeneacetamides | 2 | 2015 | 36 | 0.230 |
Why?
|
| Fenfluramine | 1 | 2024 | 58 | 0.230 |
Why?
|
| Anesthesia, General | 3 | 2016 | 1188 | 0.220 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2024 | 83 | 0.220 |
Why?
|
| Larva | 5 | 2014 | 512 | 0.210 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 665 | 0.210 |
Why?
|
| Potassium Channels | 5 | 2006 | 534 | 0.210 |
Why?
|
| Animals | 36 | 2024 | 168965 | 0.200 |
Why?
|
| Binding Sites | 5 | 2017 | 6014 | 0.200 |
Why?
|
| Methylphenidate | 3 | 2016 | 480 | 0.190 |
Why?
|
| Membrane Potentials | 6 | 2011 | 1085 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4401 | 0.180 |
Why?
|
| Biotransformation | 2 | 2011 | 165 | 0.180 |
Why?
|
| Ethylmaleimide | 3 | 2011 | 69 | 0.180 |
Why?
|
| Respiratory Rate | 2 | 2012 | 179 | 0.180 |
Why?
|
| Potassium | 1 | 2004 | 1314 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 6 | 2011 | 924 | 0.160 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2020 | 113 | 0.160 |
Why?
|
| Tidal Volume | 2 | 2012 | 519 | 0.160 |
Why?
|
| Serotonin | 1 | 2024 | 1045 | 0.160 |
Why?
|
| Postural Balance | 4 | 2016 | 638 | 0.160 |
Why?
|
| Pulmonary Ventilation | 2 | 2015 | 374 | 0.160 |
Why?
|
| Seizures | 3 | 2024 | 2996 | 0.160 |
Why?
|
| Benzamides | 2 | 2015 | 1376 | 0.150 |
Why?
|
| Plethysmography | 3 | 2013 | 172 | 0.150 |
Why?
|
| Blood Pressure | 6 | 2018 | 8531 | 0.150 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2017 | 25 | 0.150 |
Why?
|
| Infusions, Intravenous | 5 | 2016 | 2227 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2017 | 18989 | 0.140 |
Why?
|
| Cerebellum | 1 | 2004 | 1521 | 0.140 |
Why?
|
| Electroencephalography | 7 | 2016 | 6282 | 0.140 |
Why?
|
| Physostigmine | 1 | 2016 | 50 | 0.140 |
Why?
|
| Corticosterone | 3 | 2013 | 301 | 0.140 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2016 | 33 | 0.140 |
Why?
|
| Electrophysiology | 2 | 2010 | 1263 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2010 | 1677 | 0.130 |
Why?
|
| Fentanyl | 1 | 2020 | 451 | 0.130 |
Why?
|
| Reflex, Righting | 2 | 2014 | 18 | 0.130 |
Why?
|
| Reflex | 3 | 2016 | 375 | 0.130 |
Why?
|
| Ion Channel Gating | 4 | 2010 | 428 | 0.130 |
Why?
|
| Brugada Syndrome | 1 | 2017 | 98 | 0.130 |
Why?
|
| Propofol | 2 | 2014 | 608 | 0.130 |
Why?
|
| Consciousness | 1 | 2021 | 602 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 2001 | 0.120 |
Why?
|
| Arginine | 1 | 1999 | 931 | 0.120 |
Why?
|
| Blood Gas Analysis | 2 | 2013 | 383 | 0.120 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 1211 | 0.110 |
Why?
|
| Morphine | 1 | 2018 | 658 | 0.110 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 1352 | 0.110 |
Why?
|
| Ion Channels | 2 | 2010 | 1043 | 0.110 |
Why?
|
| Amino Acids | 1 | 2019 | 1712 | 0.110 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2013 | 20 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2013 | 619 | 0.110 |
Why?
|
| Propiophenones | 1 | 2013 | 28 | 0.110 |
Why?
|
| Stimulation, Chemical | 1 | 2013 | 305 | 0.110 |
Why?
|
| Respiration Disorders | 1 | 2016 | 364 | 0.100 |
Why?
|
| Death, Sudden | 1 | 2015 | 301 | 0.100 |
Why?
|
| Arousal | 2 | 2016 | 1174 | 0.100 |
Why?
|
| Temperature | 1 | 2019 | 2232 | 0.100 |
Why?
|
| Nicotinic Antagonists | 2 | 2010 | 94 | 0.100 |
Why?
|
| Mutagenesis | 2 | 2015 | 1227 | 0.100 |
Why?
|
| Indicators and Reagents | 1 | 2013 | 456 | 0.100 |
Why?
|
| Half-Life | 2 | 2012 | 648 | 0.100 |
Why?
|
| Male | 24 | 2024 | 364203 | 0.100 |
Why?
|
| Depression, Chemical | 1 | 2011 | 186 | 0.100 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2011 | 86 | 0.090 |
Why?
|
| Mice, Inbred DBA | 3 | 2017 | 624 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2005 | 2478 | 0.090 |
Why?
|
| Hemodynamics | 3 | 2011 | 4186 | 0.090 |
Why?
|
| Neurons | 3 | 2005 | 9517 | 0.090 |
Why?
|
| Anesthesia Recovery Period | 1 | 2011 | 155 | 0.090 |
Why?
|
| Epilepsy | 2 | 2017 | 3317 | 0.090 |
Why?
|
| Diazomethane | 1 | 2010 | 37 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 1377 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2017 | 1894 | 0.090 |
Why?
|
| Endotoxemia | 1 | 2012 | 198 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 13411 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2017 | 3760 | 0.090 |
Why?
|
| Benzene Derivatives | 1 | 2009 | 51 | 0.080 |
Why?
|
| Receptors, Nicotinic | 2 | 2010 | 494 | 0.080 |
Why?
|
| Esterases | 1 | 2009 | 89 | 0.080 |
Why?
|
| Cystic Fibrosis | 1 | 1999 | 1292 | 0.080 |
Why?
|
| Anesthetics, General | 1 | 2010 | 151 | 0.080 |
Why?
|
| Transfection | 3 | 2004 | 5753 | 0.080 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2010 | 161 | 0.080 |
Why?
|
| Dopamine Agonists | 1 | 2011 | 346 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2209 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2017 | 1921 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1331 | 0.070 |
Why?
|
| Anesthesia | 1 | 2018 | 1595 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5499 | 0.070 |
Why?
|
| Alcohols | 1 | 2006 | 94 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 17608 | 0.060 |
Why?
|
| Hydrocortisone | 2 | 2013 | 1840 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2012 | 1458 | 0.060 |
Why?
|
| Tetraethylammonium | 1 | 2004 | 55 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2011 | 1170 | 0.060 |
Why?
|
| Drug Design | 1 | 2010 | 1045 | 0.060 |
Why?
|
| Light | 1 | 2010 | 1358 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2004 | 405 | 0.060 |
Why?
|
| Cysteine | 2 | 1998 | 896 | 0.050 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2024 | 151 | 0.050 |
Why?
|
| Oocytes | 4 | 2010 | 1168 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 430 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 18330 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2013 | 2978 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 15567 | 0.050 |
Why?
|
| Acoustic Stimulation | 2 | 2017 | 1253 | 0.050 |
Why?
|
| Artifacts | 1 | 2011 | 1904 | 0.050 |
Why?
|
| HeLa Cells | 2 | 1998 | 3073 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1883 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9464 | 0.040 |
Why?
|
| Salts | 1 | 1999 | 60 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2677 | 0.040 |
Why?
|
| Static Electricity | 1 | 1999 | 258 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1998 | 363 | 0.040 |
Why?
|
| Humans | 13 | 2024 | 767040 | 0.040 |
Why?
|
| Stereoisomerism | 2 | 2010 | 612 | 0.040 |
Why?
|
| Species Specificity | 2 | 2016 | 2412 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2022 | 591 | 0.040 |
Why?
|
| Cytokines | 1 | 2012 | 7446 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2016 | 72 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 378 | 0.030 |
Why?
|
| Pentylenetetrazole | 1 | 2016 | 72 | 0.030 |
Why?
|
| Algorithms | 3 | 2012 | 14098 | 0.030 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2017 | 186 | 0.030 |
Why?
|
| Mice | 6 | 2024 | 81912 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2016 | 93 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1998 | 661 | 0.030 |
Why?
|
| Anesthetics, Dissociative | 1 | 2016 | 81 | 0.030 |
Why?
|
| Mutagens | 1 | 2016 | 181 | 0.030 |
Why?
|
| Models, Chemical | 1 | 1997 | 607 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 482 | 0.030 |
Why?
|
| Chloride Channels | 1 | 1996 | 221 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2010 | 12793 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2016 | 256 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2016 | 242 | 0.030 |
Why?
|
| Alanine | 1 | 1997 | 613 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1743 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4167 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 1337 | 0.030 |
Why?
|
| Heart Rate | 2 | 2017 | 4209 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 1837 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1997 | 1504 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 5754 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 2626 | 0.020 |
Why?
|
| Hippocampus | 1 | 2005 | 3777 | 0.020 |
Why?
|
| Droperidol | 1 | 2011 | 21 | 0.020 |
Why?
|
| Octanols | 1 | 2011 | 25 | 0.020 |
Why?
|
| Necrosis | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Alkalosis, Respiratory | 1 | 2011 | 20 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2011 | 58 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 9551 | 0.020 |
Why?
|
| Drug Stability | 1 | 2011 | 289 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1999 | 3948 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 849 | 0.020 |
Why?
|
| Heme | 1 | 2013 | 316 | 0.020 |
Why?
|
| Brain Stem | 1 | 2016 | 858 | 0.020 |
Why?
|
| Deep Sedation | 1 | 2012 | 119 | 0.020 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2010 | 23 | 0.020 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2010 | 45 | 0.020 |
Why?
|
| Torpedo | 1 | 2010 | 170 | 0.020 |
Why?
|
| Photoaffinity Labels | 1 | 2010 | 85 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 365 | 0.020 |
Why?
|
| Ketamine | 1 | 2016 | 527 | 0.020 |
Why?
|
| Cell Division | 1 | 2017 | 4473 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2011 | 198 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1998 | 3642 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 424 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6507 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3738 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 9513 | 0.020 |
Why?
|
| Solubility | 1 | 2010 | 1078 | 0.020 |
Why?
|
| Female | 6 | 2024 | 396660 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2394 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 391 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4280 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 1531 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2011 | 996 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 720 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 1502 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1882 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 940 | 0.020 |
Why?
|
| Pentanols | 1 | 2006 | 4 | 0.020 |
Why?
|
| Hexanols | 1 | 2006 | 6 | 0.020 |
Why?
|
| Butanols | 1 | 2006 | 19 | 0.020 |
Why?
|
| Brain | 2 | 2012 | 27163 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 5750 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1182 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 1027 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2721 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2004 | 46 | 0.020 |
Why?
|
| Water | 1 | 2011 | 1419 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2005 | 140 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2004 | 79 | 0.010 |
Why?
|
| Cattle | 1 | 2010 | 3813 | 0.010 |
Why?
|
| Kinetics | 1 | 2012 | 6287 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 1139 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 861 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 526 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3273 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6409 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 1135 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 789 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14476 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 561 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3227 | 0.010 |
Why?
|
| Zinc | 1 | 2005 | 675 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 903 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2551 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 16718 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 17097 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40154 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11923 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 1005 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22361 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4572 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2011 | 6260 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2004 | 1811 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 1494 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5098 | 0.010 |
Why?
|
| Protein Transport | 1 | 2000 | 1944 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 8310 | 0.010 |
Why?
|
| Neoplasms | 1 | 2017 | 22350 | 0.000 |
Why?
|